NDC 0093-7487-19 - Montelukast Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0093-7487
- Requested NDC
- 0093-7487-19
- Package NDCs from labels
- 0093-7487-19, 0093-7487-56
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Effective date
- 2021-05-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Montelukast Sodium - Teva Pharmaceuticals USA, Inc. | Teva Pharmaceuticals USA, Inc. | 2021-05-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0093-7487-19 | EA - Each | 0093-7487 | ee113742-0e03-42e2-ae71-dfd372fc85a8 | 1 | 2018-01-12 |
| 0093-7487-56 | EA - Each | 0093-7487 | 360488ce-c5c5-4e72-99f3-e8eccca8c231 | 1 | 2018-01-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Montelukast Sodium | MONTELUKAST SODIUM | PD-Rx Pharmaceuticals, Inc. | 6ffff72c-8784-477b-8722-5434a19881a0 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| TRIMO SAN | OXYQUINOLINE SULFATE AND SODIUM LAURYL SULFATE | CooperSurgical, Inc. | 1e4a1caa-e6ba-44ef-8347-07e6385a7c9e | 2025-09-03 | Warnings | 368GB5141J |
| MONTELUKAST SODIUM | MONTELUKAST SODIUM | Ajanta Pharma USA Inc. | 67070e4e-f755-46b3-b900-fcc1993a0546 | 2025-08-29 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| Montelukast Sodium | MONTELUKAST SODIUM | Major Pharmaceuticals | a4dc63cf-8145-42f4-9437-93b414d2aed4 | 2025-06-19 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast | MONTELUKAST | Sandoz Inc | 6d69e73a-76cb-4ece-9cf9-e9adb4f523b4 | 2025-06-13 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast | MONTELUKAST | NuCare Pharmaceuticals, Inc. | 365e1c5c-01b2-bf4e-e063-6394a90a0e43 | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2025-05-20 | Warnings, Adverse reactions | 3OWL53L36A |
| SINGULAIR | MONTELUKAST SODIUM | Organon LLC | 482dcc92-b47f-4ea6-854a-f5ac2aea7842 | 2025-04-30 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast Sodium | MONTELUKAST | Amneal Pharmaceuticals LLC | bcd49102-a21c-4628-a322-6cdd934e7f09 | 2025-04-18 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| MONTELUKAST SODIUM | MONTELUKAST SODIUM | Camber Pharmaceuticals, Inc. | 97a682c2-7e00-4d07-a5ac-4436c977f842 | 2025-03-13 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Montelukast | MONTELUKAST | Quallent Pharmaceuticals Health LLC | 5d71088b-b0fa-4bf0-a6e7-6163bd9e0dd4 | 2025-02-28 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| MONTELUKAST SODIUM | MONTELUKAST SODIUM | Direct_Rx | f3bdf2a3-d661-5128-e053-2995a90a4661 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| montelukast sodium | MONTELUKAST SODIUM | NuCare Pharmaceuticals,Inc. | a7c11cbe-0834-27a5-e053-2995a90ac43f | 2024-12-30 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PROPYLPARABEN, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR, PARAFFINUM | Energique, Inc. | f3db63df-62a4-48d6-92e7-94e4a5701552 | 2024-12-20 | Warnings | 368GB5141J |
| Montelukast Sodium | MONTELUKAST SODIUM | American Health Packaging | fb1b2e4e-a840-447b-b943-ad0b6acc32b5 | 2024-10-31 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| montelukast sodium | MONTELUKAST SODIUM | Bryant Ranch Prepack | 3ff4100f-11e3-4d6a-ab88-83bd605a1818 | 2024-10-07 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | Energique, Inc. | 87c92497-8a51-4977-87fe-e0b4c6bafb19 | 2024-09-27 | Warnings | 368GB5141J |
| Montelukast | MONTELUKAST | Bryant Ranch Prepack | 6b26218d-52a6-4109-90e4-412a17d14fcf | 2024-08-08 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
| MONTELUKAST SODIUM | MONTELUKAST SODIUM | Rising Pharma Holdings, Inc. | 75723c5a-3c9e-468a-bc65-57b4c755889a | 2024-07-26 | Boxed warning, Warnings, Adverse reactions | U1O3J18SFL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.